early onset-mutant (BRCA1) breast cancer, beta-catenin-driven colon cancer model, sarcomas, lymphomas, teratomas, and carcinomas arising from deletion of p53, HFD-induced hepatocarcinomas, and age-associated spontaneous tumor development. Here, CTNNB1 is linked to neoplasm.